Search results for "Harm"

showing 10 items of 13866 documents

An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge

2018

Molecular dynamics (MD) has become increasingly popular due to the development of hardware and software solutions and the improvement in algorithms, which allowed researchers to scale up calculations in order to speed them up. MD simulations are usually used to address protein folding issues or protein-ligand complex stability through energy profile analysis over time. In recent years, the development of new tools able to deeply explore a potential energy surface (PES) has allowed researchers to focus on the dynamic nature of the binding recognition process and binding-induced protein conformational changes. Moreover, modern approaches have been demonstrated to be effective and reliable in …

0301 basic medicinePharmacologyVirtual screeningDrug discoveryComputer scienceOrganic ChemistryRational designPharmaceutical ScienceComputational biologyBiochemistrySmall moleculeSettore CHIM/08 - Chimica FarmaceuticaChemistry03 medical and health sciencesMolecular dynamics030104 developmental biology0302 clinical medicineDocking (molecular)030220 oncology & carcinogenesisDrug DiscoveryMolecular MedicineProtein foldingPharmacophoreMolecular Dynamics undruggable target computational studies
researchProduct

Chemoresistance and chemosensitization in cholangiocarcinoma

2017

One of the main difficulties in the management of patients with advanced cholangiocarcinoma (CCA) is their poor response to available chemotherapy. This is the result of powerful mechanisms of chemoresistance (MOC) of quite diverse nature that usually act synergistically. The problem is often worsened by altered MOC gene expression in response to pharmacological treatment. Since CCA includes a heterogeneous group of cancers their genetic signature coding for MOC genes is also diverse; however, several shared traits have been defined. Some of these characteristics are shared with other types of liver cancer, namely hepatocellular carcinoma and hepatoblastoma. An important goal in modern onco…

0301 basic medicinePharmacologybile ductschemotherapydrug delivery systems0302 clinical medicineChemosensitizationantineoplastic agentsmolecular biologyReceptorhumansreceptor protein-tyrosine kinasesmedia_commonapoptosisgene expression regulationbile duct neoplasmsDrug Resistance Multipletargeted therapiesGene Expression Regulation Neoplasticmultiplebiliary cancer; chemotherapy; liver cancer; multidrug resistance; targeted therapies; antineoplastic agents; apoptosis; bile duct neoplasms; bile ducts; cell survival; cholangiocarcinoma; drug delivery systems; drug resistance multiple; drug resistance; neoplasm; epithelial cells; gene expression regulation neoplastic; genetic therapy; humans; protein kinase inhibitors; receptor protein-tyrosine kinases; signal transduction; treatment outcome; molecular medicine; molecular biology030220 oncology & carcinogenesisHepatocellular carcinomabiliary cancerLiver cancercholangiocarcinomaTyrosine kinasesignal transductionDrugHepatoblastomamedia_common.quotation_subjectcell survivalPharmacological treatmentliver cancer03 medical and health sciencesmultidrug resistancemedicinemolecular medicinedrug resistancebusiness.industrymedicine.diseaseepithelial cellsneoplasticprotein kinase inhibitors030104 developmental biologyDrug Resistance NeoplasmCancer researchtreatment outcomebusinessneoplasmgenetic therapy
researchProduct

Substrate Specificity of Aglaia loheri Active Isolate towards P-glycoprotein in Multidrug-Resistant Cancer Cells

2016

Multidrug resistance (MDR) is a major contributory factor in the failure of chemotherapy. Concrete interpretation of P-glycoprotein (P-gp) substrate specificity, whether a substance is a substrate or an inhibitor, represents an important feature of a compound's pharmaceutical profiling in drug design and development. In this work, the P-gp substrate specificity of Maldi 531.2[M+H]+, a phenol ester from Aglaia loheri Blanco leaves was investigated. This study focuses on the effect of Maldi 531.2[M+H]+ on P-gp ATPase activity, which was examined by measuring the amount of inorganic phosphates (Pi) released as a result of ATP hydrolysis. To test the effects of Maldi 531.2[M+H]+ on MDR activit…

0301 basic medicinePharmacologybiologyChemistryStereochemistryStimulationPlant ScienceGeneral MedicineMultiple drug resistance03 medical and health sciences030104 developmental biology0302 clinical medicineNon-competitive inhibitionComplementary and alternative medicineATP hydrolysis030220 oncology & carcinogenesisDrug DiscoveryCancer cellmedicinebiology.proteinPiVerapamilmedicine.drugP-glycoproteinNatural Product Communications
researchProduct

2019

Abstract Type B Coxsackieviruses (CVBs) are a common cause of acute and chronic myocarditis, dilated cardiomyopathy and aseptic meningitis. However, no CVB-vaccines are available for human use. We have previously produced virus-like particles (VLPs) for CVB3 with a baculovirus-insect cell production system. Here we have explored the potential of a VLP-based vaccine targeting CVB1 and describe the production of CVB1-VLPs with a scalable VLP purification method. The developed purification method consisting of tangential flow filtration and ion exchange chromatography is compatible with industrial scale production. CVB1-VLP vaccine was treated with UV-C or formalin to study whether stability a…

0301 basic medicinePharmacologybiologyChemistryvirusesImmunogenicity030106 microbiologyCellIndustrial scalevirus diseasesAseptic meningitisAntibody levelCoxsackievirusmedicine.diseasebiology.organism_classificationcomplex mixturesVirology3. Good health03 medical and health sciences030104 developmental biologyAntibody responsemedicine.anatomical_structureVirus-like particleVirologymedicineAntiviral Research
researchProduct

Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis

2018

The commensal gut microbiota is an environmental factor that has been implicated in the development of cardiovascular disease. The development of atherosclerotic lesions is largely influenced not only by the microbial-associated molecular patterns of the gut microbiota but also by the meta-organismal trimethylamine N-oxide pathway. Recent studies have described a role for the gut microbiota in platelet activation and arterial thrombosis. This review summarizes the results from gnotobiotic mouse models and clinical data that linked microbiota-induced pattern recognition receptor signalling with atherogenesis. Based on recent insights, we here provide an overview of how the gut microbiota cou…

0301 basic medicinePharmacologybiologybusiness.industryGastrointestinal MicrobiomePattern recognition receptorDiseaseGut florabiology.organism_classificationmedicine.diseasedigestive systemThrombosis03 medical and health sciences030104 developmental biologyImmunologyMedicinePlatelet activationMicrobiomebusinessBritish Journal of Pharmacology
researchProduct

Antibiotic use and microbiome function.

2017

Our microbiome should be understood as one of the most complex components of the human body. The use of β-lactam antibiotics is one of the microbiome covariates that influence its composition. The extent to which our microbiota changes after an antibiotic intervention depends not only on the chemical nature of the antibiotic or cocktail of antibiotics used to treat specific infections, but also on the type of administration, duration and dose, as well as the level of resistance that each microbiota develops. We have begun to appreciate that not all bacteria within our microbiota are vulnerable or reactive to different antibiotic interventions, and that their influence on both microbial comp…

0301 basic medicinePharmacologybiologymedicine.drug_classMicrobiota030106 microbiologyAntibioticsMicrobial compositionbiology.organism_classificationBiochemistryMicrobiologyAnti-Bacterial Agents03 medical and health sciences030104 developmental biologymedicineAnimalsHumansMicrobiomeAntibiotic useBacteriaFunction (biology)Biochemical pharmacology
researchProduct

How β3 -adrenoceptor-selective is mirabegron?

2016

0301 basic medicinePharmacologybusiness.industryAdrenergic beta-3 Receptor AgonistsPharmacology03 medical and health sciences030104 developmental biology0302 clinical medicinemedicineβ3 adrenoceptorMirabegronbusiness030217 neurology & neurosurgerymedicine.drugBritish Journal of Pharmacology
researchProduct

Editorial (Thematic Issue: Myokines and Exercise Training: More Shadows than Lights).

2016

0301 basic medicinePharmacologybusiness.industryApplied psychologyMEDLINEMuscle Proteins03 medical and health sciences030104 developmental biologyThematic mapMyokineDrug DiscoveryMedicineHumansbusinessMuscle SkeletalExerciseCurrent pharmaceutical design
researchProduct

Stimulation of autophagy prevents intestinal mucosal inflammation and ameliorates murine colitis

2017

Background and pourpose A defective autophagy is involved in the pathogenesis of inflammatory disorders such as IBD. Cross talk interactions between autophagy and inflammation have been reported and we analyse the effects of autophagy stimulators on murine colitis. Experimental approach Mice were treated with intrarectal administration of TNBS (3.5 mg/20 g BW) and body weight was measured every day and histological damage score analysed two or four days after treatment. Some mice received trehalose (3% in drinking water three weeks before TNBS administration) or a daily administration of rapamycin (1.25 mg/kg, i.p.), betanin (1g/kg, i.p.) or betanin + 3MA (10mg/kg, i.p.). Mucosal protein le…

0301 basic medicinePharmacologybusiness.industryAutophagyInflammationStimulationPharmacologymedicine.diseaseInflammatory bowel diseasePathogenesis03 medical and health sciencesIκBαchemistry.chemical_compound030104 developmental biologychemistryMedicineTumor necrosis factor alphamedicine.symptombusinessBetaninBritish Journal of Pharmacology
researchProduct

2019

Background: Network science provides powerful access to essential organizational principles of the brain. The aim of this study was to investigate longitudinal evolution of gray matter networks in early relapsing–remitting MS (RRMS) compared with healthy controls (HCs) and contrast network dynamics with conventional atrophy measurements. Methods: For our longitudinal study, we investigated structural cortical networks over 1 year derived from 3T MRI in 203 individuals (92 early RRMS patients with mean disease duration of 12.1 ± 14.5 months and 101 HCs). Brain networks were computed based on cortical thickness inter-regional correlations and fed into graph theoretical analysis. Network conne…

0301 basic medicinePharmacologybusiness.industryMultiple sclerosisGraph theoryNetwork sciencemedicine.disease03 medical and health sciences030104 developmental biology0302 clinical medicineNeurologyRelapsing remittingCortical networkStructural covariancemedicineNeurology (clinical)businessNeuroscience030217 neurology & neurosurgeryTherapeutic Advances in Neurological Disorders
researchProduct